People · Operator
Named in public records as an officer, director or promoter · active 2009–2020 · Other Health Care, Biotechnology, Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Ebh Holding Company, Inc. | — | Other Health Care | Series B | $70.9M | $871.1M | 2015 |
| NuPulseCV, Inc. | — | Biotechnology | Series A | $14.7M | $75.9M | 2018 |
| Pharmaca Integrative Pharmacy Inc | — | Biotech / Pharma | Series A | $13.6M | $234.5M | 2009 |
Greg Scott at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Greg Scott on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mohamad Makhzoumi | 1 | 10 |
| Nader Naini | 1 | 6 |
| Thomas Cooper | 1 | 6 |
| William Rosenzweig | 1 | 5 |
| Richard Willis | 1 | 5 |
| Richard Whitney | 1 | 5 |
| Corey Mulloy | 1 | 5 |
| Douglas Godshall | 1 | 4 |
| Thomas Stemberg | 1 | 3 |
| RICHARD SHERMAN | 1 | 3 |
| Jennifer Gallagher | 1 | 3 |
| Joel D. Liffmann | 1 | 3 |
| Rob Mahan | 1 | 2 |
| Peter Cornetta | 1 | 2 |
| David Sack | 1 | 2 |
| Chris Karkenny | 1 | 2 |
| Alan Kessock | 1 | 2 |
| Jim Adams | 1 | 2 |
| Martin Hanaka | 1 | 2 |
| BRIAN NOVACK | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.